Avalere Health at www.avalere.com is expanding internationally by offering services in reimbursement and health economics for life sciences companies. To accomplish this goal, the company has initiated a partnership with Pope Woodhead & Associates, a European-based consultancy with thirty years of expertise in partnering with life science companies.
“Evidence is global, but healthcare decisions to purchase, prescribe, and use technologies are local. Global life science companies must embrace a global view in how they think about data and evidence, but incorporate the local needs of each market,” said Dan Mendelson, CEO of Avalere Health.
Pope Woodhead specialties include regulatory strategy, pricing and finding market access solutions for successful entry into European and emerging country markets. “Over the last year, we successfully partnered with Avalere Health on a number of projects involving thought leadership initiatives, and client events,” reports Andrew Hobbs, Managing Director, Pope Woodhead& Associates.
The complementary nature of the partnership will also expand the geographic reach of Avalere’s offerings in delivering client tools and solutions that will reflect the values and priorities of the decision-makers in the U.S., European, and emerging markets.
In addition, each partner brings on-the-round insight and deep investments in analytics of the payer, provider, and prescriber trends in each country that can lead to research, regulatory, and commercial strategies that will resonate with decision-makers in each country.